Get the Stockscreener App
2.365
3.47%
-0.085
Biocardia Inc Stock (BCDA) Forecast
The Biocardia Inc (BCDA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.5274, representing a -77.70% decrease from the current price of $2.365. The highest analyst price target is $0.963, and the lowest is $0.0917.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BCDA Price Target
Average 2.6675
(+12.79% Upside)
Is Biocardia Inc (BCDA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 52.52 | Neutral |
| STOCH(9,6) | 62.13 | Neutral |
| STOCHRSI(14) | 38.28 | Neutral |
| MACD(12,26) | 0.0703 | Buy |
| ADX(14) | 19.29 | Neutral |
| William %R | -54.48 | Neutral |
| CCI(14) | 45.48 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.4075
Sell
|
2.3998
Sell
|
| MA20 |
2.2886
Buy
|
2.3363
Buy
|
| MA50 |
2.2322
Buy
|
2.3004
Buy
|
| MA100 |
2.3769
Sell
|
2.5007
Sell
|
| MA200 |
3.0759
Sell
|
3.4137
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, BCDA could be considered a Neutral, with 17 technical analysis indicators signaling 5 Buy signals, 6 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on BCDA, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 52.52 indicates that BCDA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 62.13 indicates that BCDA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 38.28 indicates that BCDA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 19.29 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 45.48 indicates that BCDA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term BCDA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Biocardia Inc financial reports and earnings history, Biocardia Inc (BCDA) stock could reach $4.5503 by 2030, $1.296 by 2040 and $3.9423 by 2050. See the projected annual prices until 2050 of the Biocardia Inc stock below:
- Biocardia Inc (BCDA) is expected to reach an average price of $7.8953 in 2035, with a high prediction of $8.5033 and a low estimate of $8.5076. This indicates an $233.84% rise from the last recorded price of $2.365.
- Biocardia Inc (BCDA) stock is projected to chart a bullish course in 2040, with an average price target of $1.2088, representing an $-48.89% surge from its current level. The forecast ranges from a conservative $1.2518 to a sky-high $1.296.
- Our analysts predict Biocardia Inc (BCDA) to jump 18.82% by 2045, soaring from $2.8501 to an average price of $2.81, potentially reaching $2.9417. While $2.8501 is the low estimate, the potential upside is significant.
- Biocardia Inc (BCDA) stock is expected to climb by 2050, reaching an average of $4.2863, a $81.24% jump from its current level. However, a wide range of estimates exists, with high and low targets of $3.9423 and $2.9529, respectively, highlighting the market's uncertainty.
Biocardia Inc Stock (BCDA) Year by Year Forecast
Biocardia Inc Stock (BCDA) Price Forecast for 2025
Biocardia Inc Stock (BCDA) is expected to reach an average price of $2.6646 in 2025, with a high prediction of $5.3128 and a low estimate of $0.0164. This indicates an +12.67% rise from the last recorded price of $2.365.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $0.3824 | $0.0917 | $0.963 | -83.83% |
| April, 2025 | $1.3341 | $0.4029 | $1.1388 | -43.59% |
| May, 2025 | $1.1253 | $1.2353 | $1.1547 | -52.42% |
| June, 2025 | $1.2265 | $1.1506 | $0.9565 | -48.14% |
| July, 2025 | $1.123 | $1.2568 | $1.1724 | -52.52% |
| August, 2025 | $1.1342 | $1.1442 | $1.0708 | -52.04% |
| September, 2025 | $1.2871 | $1.2895 | $1.2901 | -45.58% |
| October, 2025 | $0.4919 | $0.7419 | $0.956 | -79.20% |
| November, 2025 | $0.557 | $0.0223 | $5.3128 | -76.45% |
| December, 2025 | $1.9605 | $0.2017 | $2.3105 | -17.11% |
Biocardia Inc Stock (BCDA) Price Forecast for 2026
The predicted value for Biocardia Inc (BCDA) in 2026 is set at an average of $1.1244. Estimates vary from a peak of $2.2233 to a trough of $0.0254, indicating an -52.46% surge from the present price of $2.365.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.8893 | $0.0254 | $2.0252 | -62.40% |
| February, 2026 | $1.3681 | $0.6934 | $1.644 | -42.15% |
| March, 2026 | $0.5469 | $0.3972 | $1.8628 | -76.88% |
| April, 2026 | $1.6104 | $0.2428 | $1.8804 | -31.91% |
| May, 2026 | $1.1092 | $0.9792 | $2.2233 | -53.10% |
| June, 2026 | $0.908 | $0.4333 | $1.2025 | -61.61% |
| July, 2026 | $0.1915 | $0.0268 | $0.9726 | -91.90% |
| August, 2026 | $0.4403 | $0.1003 | $0.6422 | -81.38% |
| September, 2026 | $0.3638 | $0.1591 | $1.305 | -84.62% |
| October, 2026 | $0.0974 | $0.0832 | $0.4437 | -95.88% |
| November, 2026 | $0.5985 | $0.3727 | $0.3385 | -74.69% |
| December, 2026 | $0.715 | $0.4998 | $0.4791 | -69.77% |
Biocardia Inc Stock (BCDA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Biocardia Inc (BCDA) is $0.3739, with a high forecast of $0.6949 and a low forecast of $0.0529. This indicates an -84.19% decrease from the last price of $2.365.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.4962 | $0.7403 | $0.6709 | -79.02% |
| February, 2027 | $0.1474 | $0.3021 | $0.5332 | -93.77% |
| March, 2027 | $0.0739 | $0.1866 | $0.0927 | -96.87% |
| April, 2027 | $0.6651 | $0.1198 | $0.6949 | -71.88% |
| May, 2027 | $0.6963 | $0.6257 | $0.6063 | -70.56% |
| June, 2027 | $0.5828 | $0.4272 | $0.4016 | -75.36% |
| July, 2027 | $0.504 | $0.514 | $0.4881 | -78.69% |
| August, 2027 | $0.4552 | $0.4299 | $0.325 | -80.75% |
| September, 2027 | $0.1583 | $0.0964 | $0.3536 | -93.31% |
| October, 2027 | $0.0871 | $0.0529 | $0.2824 | -96.32% |
| November, 2027 | $0.3459 | $0.0618 | $0.4365 | -85.37% |
| December, 2027 | $0.234 | $0.1095 | $0.3606 | -90.11% |
Biocardia Inc Stock (BCDA) Price Forecast for 2028
In 2028, Biocardia Inc (BCDA) is projected to reach an average price of $0.9015, with a high projection of $1.796 and a low estimate of $0.00703. This indicates an -61.88% fall from the last price of $2.365.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.1483 | $0.0183 | $0.408 | -93.73% |
| February, 2028 | $0.8671 | $0.00703 | $0.917 | -63.34% |
| March, 2028 | $0.9306 | $0.7412 | $1.1359 | -60.65% |
| April, 2028 | $0.8094 | $0.6254 | $1.0879 | -65.78% |
| May, 2028 | $0.6329 | $0.5282 | $0.9088 | -73.24% |
| June, 2028 | $0.8017 | $0.6076 | $0.8717 | -66.10% |
| July, 2028 | $0.6605 | $0.3205 | $0.8864 | -72.07% |
| August, 2028 | $1.454 | $0.5652 | $1.7939 | -38.52% |
| September, 2028 | $0.9128 | $0.8828 | $1.796 | -61.40% |
| October, 2028 | $0.1205 | $0.1078 | $0.2675 | -94.91% |
| November, 2028 | $0.4747 | $0.1537 | $0.2334 | -79.93% |
| December, 2028 | $0.476 | $0.4907 | $0.4925 | -79.87% |
Biocardia Inc Stock (BCDA) Price Forecast for 2029
The 2029 price forecast for Biocardia Inc Stock (BCDA) is $2.2694 on average, with a high prediction of $4.5326 and a low estimate of $0.00618. This represents an -4.04% decrease from the previous price of $2.365.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.4024 | $0.4425 | $0.4319 | -82.98% |
| February, 2029 | $0.1225 | $0.153 | $0.7769 | -94.82% |
| March, 2029 | $0.0349 | $0.0659 | $0.0597 | -98.52% |
| April, 2029 | $0.1891 | $0.0206 | $0.0638 | -92.00% |
| May, 2029 | $0.1036 | $0.1466 | $0.132 | -95.62% |
| June, 2029 | $0.0727 | $0.0235 | $0.0962 | -96.93% |
| July, 2029 | $0.0495 | $0.0562 | $0.0444 | -97.91% |
| August, 2029 | $0.0229 | $0.00618 | $0.0396 | -99.03% |
| September, 2029 | $3.9396 | $4.0884 | $4.0988 | +66.58% |
| October, 2029 | $5.1563 | $4.2057 | $4.5326 | +118.02% |
| November, 2029 | $4.265 | $4.335 | $4.1058 | +80.34% |
| December, 2029 | $3.9372 | $4.8761 | $4.3767 | +66.48% |
Biocardia Inc Stock (BCDA) Price Forecast for 2030
Biocardia Inc Stock (BCDA) is expected to reach an average price of $3.9399 in 2030, with a high forecast of $4.8376 and a low forecast of $3.0422. This signifies an +66.59% surge from the last price of $2.365.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.5703 | $4.3179 | $4.5503 | +93.25% |
| February, 2030 | $3.1119 | $3.1327 | $3.9709 | +31.58% |
| March, 2030 | $3.6351 | $3.4033 | $3.5151 | +53.70% |
| April, 2030 | $4.8475 | $4.2863 | $4.1475 | +104.97% |
| May, 2030 | $4.5805 | $4.9005 | $4.7082 | +93.68% |
| June, 2030 | $3.3628 | $3.0422 | $4.2811 | +42.19% |
| July, 2030 | $4.0358 | $3.4766 | $3.3458 | +70.65% |
| August, 2030 | $5.0182 | $5.0882 | $4.8376 | +112.19% |
| September, 2030 | $4.7506 | $4.8606 | $4.8187 | +100.87% |
| October, 2030 | $4.7536 | $4.7612 | $4.7036 | +101.00% |
| November, 2030 | $4.616 | $4.786 | $4.6948 | +95.18% |
| December, 2030 | $4.5683 | $4.5783 | $4.5366 | +93.16% |
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):